Standard BioTools Inc. (NASDAQ:LAB - Get Free Report) shares gapped up before the market opened on Monday . The stock had previously closed at $1.05, but opened at $1.20. Standard BioTools shares last traded at $1.42, with a volume of 8,634,191 shares traded.
Wall Street Analyst Weigh In
Separately, KeyCorp lowered shares of Standard BioTools from an "overweight" rating to a "sector weight" rating in a research report on Thursday, February 27th.
Read Our Latest Stock Analysis on LAB
Standard BioTools Stock Up 24.3%
The firm has a market capitalization of $495.67 million, a PE ratio of -3.70 and a beta of 1.50. The business's 50-day moving average price is $1.09 and its 200-day moving average price is $1.34.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently bought and sold shares of the company. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in shares of Standard BioTools by 80.6% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 554,203 shares of the company's stock worth $970,000 after purchasing an additional 247,332 shares during the last quarter. Invesco Ltd. raised its position in shares of Standard BioTools by 7.5% during the 4th quarter. Invesco Ltd. now owns 175,041 shares of the company's stock valued at $306,000 after acquiring an additional 12,194 shares during the last quarter. ProShare Advisors LLC increased its stake in shares of Standard BioTools by 49.0% in the 4th quarter. ProShare Advisors LLC now owns 83,074 shares of the company's stock valued at $145,000 after acquiring an additional 27,334 shares during the last quarter. Northern Trust Corp boosted its position in shares of Standard BioTools by 9.3% during the fourth quarter. Northern Trust Corp now owns 2,875,160 shares of the company's stock worth $5,032,000 after purchasing an additional 243,522 shares in the last quarter. Finally, MetLife Investment Management LLC lifted its holdings in Standard BioTools by 27.9% during the fourth quarter. MetLife Investment Management LLC now owns 183,382 shares of the company's stock worth $321,000 after acquiring an additional 40,057 shares in the last quarter. Institutional investors and hedge funds own 53.74% of the company's stock.
About Standard BioTools
(
Get Free Report)
Standard BioTools Inc, together with its subsidiaries, provides instruments, consumables, reagents, and software services for researchers and clinical laboratories in the Americas, Europe, the Middle East, Africa, and the Asia pacific. It operates through two segments: Proteomics and Genomics. The company offers analytical systems, such as CyTOF XT System, a CyTOF XT mass cytometry system performs automated high-parameter single-cell analysis using antibodies conjugated to metal isotopes; and Hyperion XTi imaging system, a spatial biology instrument.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Standard BioTools, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Standard BioTools wasn't on the list.
While Standard BioTools currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
